SCHEMBL630334

SCHEMBL630334

CCCCCCC(CCC)CC(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 11/20 0.62
FFAR1 O14842 3/20 0.50
FFAR4 Q5NUL3 2/20 0.50
LMNA P02545 1/20 0.50
PPARD Q03181 7/20 0.48
MAPT P10636 1/20 0.48
LCK P06239 1/20 0.48
ZDHHC20 Q5W0Z9 1/20 0.48
ZDHHC2 Q9UIJ5 1/20 0.48
PPARG P37231 6/20 0.46
PPARA Q07869 6/20 0.46
HDAC11 Q96DB2 5/20 0.46
TSHR P16473 4/20 0.46
ALDH1A1 P00352 2/20 0.46
TLR2 O60603 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
FABP4 P15090 2/20 0.46
PTPN1 P18031 2/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
SLC22A8 Q8TCC7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9580237 1.00 GPR84 (0.62) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL8608486 1.00 GPR84 (0.62) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL5879075 1.00 GPR84 (0.62) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL29067690 1.00 GPR84 (0.62) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL5879043 1.00 GPR84 (0.62) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL23249652 1.00 GPR84 (0.62) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL28953563 1.00 GPR84 (0.62) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL5878852 1.00 GPR84 (0.62) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL8133996 1.00 GPR84 (0.62) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL27642501 1.00 GPR84 (0.62) GPR84FFAR1FFAR4LMNAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116685575-A Novel cooling substances and formulations containing these cooling substances 西姆莱斯股份公司 2023-09-01 CN claimed
CN-115433832-A Nickel and cobalt synergistic extraction agent and application thereof 中国科学院过程工程研究所 2022-12-06 CN claimed
CN-118000374-A Method for preparing high-quality probiotic fermented strawberry juice based on magnetic field assistance 中华全国供销合作总社济南果品研究所 2024-05-10 CN disclosed
CN-115433832-B Nickel and cobalt synergistic extractant and application thereof 中国科学院过程工程研究所 2024-03-19 CN disclosed
CN-116685575-A Novel cooling substances and formulations containing these cooling substances 西姆莱斯股份公司 2023-09-01 CN disclosed
CN-110650738-B Compounds and methods for treating parasitic diseases 博德研究所 2023-05-09 CN disclosed
CN-115433832-A Nickel and cobalt synergistic extraction agent and application thereof 中国科学院过程工程研究所 2022-12-06 CN disclosed
CN-105579450-A Novel indolizine compounds, process for their preparation and pharmaceutical compositions containing them SERVIER LAB 2016-05-11 CN disclosed
CN-103732583-B TRPV4 antagonist GLAXOSMITHKLINE LLC (GB) 2015-12-23 CN disclosed
CN-104876927-A APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LAB 2015-09-02 CN disclosed
CN-102448959-B Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases ABBVIE BAHAMAS LTD 2015-06-17 CN disclosed
WO-2010119425-A1 A PROCESS FOR THE PREPARATION OF 1, 2, 4-TRIOXOLANE ANTIMALARIALS RANBAXY LABORATORIES LIMITED (IN) 2010-10-21 WO disclosed
EP-2029569-A2 A PROCESS FOR THE PREPARATION OF SPIRO AND DISPIRO 1,2,4-TRIOXOLANE ANTIMALARIALS (OZ277) Ranbaxy Laboratories Limited (IN) 2009-03-04 EP disclosed
CN-100430405-C Processes for preparing calcium salt forms of statins TEVA PHARMA (IL) 2008-11-05 CN disclosed
WO-2007138435-A2 A PROCESS FOR THE PREPARATION OF DISPIRO 1,2,4-TRIOXOLANE ANTIMALARIALS (OZ277) RANBAXY LABORATORIES LIMITED (IN) 2007-12-06 WO disclosed
CN-101014598-A Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes MERCK & CO INC (US) 2007-08-08 CN disclosed
CN-1543468-A Processes for preparing calcium salt forms of statins ������ҩ��ҵ���޹�˾ 2004-11-03 CN disclosed
US-6251946-B1 SATURATED OR UNSATURATED BRANCHED FATTY ACID CONTAINING LIPID ESTER OR FATTY ACID AMIDE TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS, INCLUDING EPILEPSY, MIGRAINES, CHRONIC PAIN AND BIPOLAR DISORDERS D-PHARM LTD. (IL) 2001-06-26 US disclosed
EP-1009734-A1 BRANCHED CHAIN FATTY ACIDS, THEIR DERIVATIVES AND USE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS D-PHARM, LTD. (IL) 2000-06-21 EP disclosed
WO-1999002485-A1 BRANCHED CHAIN FATTY ACIDS, THEIR DERIVATIVES AND USE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS D-PHARM LTD. (IL) 1999-01-21 WO disclosed